EGFR and dermatological toxicity: Furthermore, despite the high incidence of skin toxicity, generic quality of life (QoL) instruments have shown no impact of EGFR inhibitors plus FOLFIRI on overall QoL (Melosky et al, 2009; Bennett et al, 2011; Thaler et al, 2012).